North American Pediatric Renal Tra… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1999

Legal Domicile

Principal Officer

Alicia Neu MD

Phone

7819449868

Tax Period

2024-01-01 to 2024-12-31

North American Pediatric Renal Transplant Case Study Inc, founded in 1999, is a small nonprofit in the Medical Research sector that reported $794K in total revenue in fiscal year 2024. Revenue surged 49% from the prior year, signaling strong growth momentum.

Mission

To register and monitor greater than 80% of the children receiving renal allografts in North America, and to study the clinical course and natural history of patients with renal dysfunction.

Program Service Accomplishments

Program 1

Expenses: $651,754 Revenue: $793,612

Collecting information, analyzing case studies and providing education regarding renal transplants to improve the quality of life for the transplant recipients. NAPRTCS works with pharmaceutical...

Collecting information, analyzing case studies and providing education regarding renal transplants to improve the quality of life for the transplant recipients. NAPRTCS works with pharmaceutical companies to conduct clinical trials.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $598,612

Program Service Revenue $195,000

Investment Income $0

Other Revenue $527

TOTAL REVENUE $794,139

Expense Breakdown

Grants Paid $0

Salaries & Benefits $96,359

Fundraising Expenses $0

Program Expenses $651,754

Other Expenses $742,421

TOTAL EXPENSES $838,780

Year-over-Year Comparison

	2024	2023	Change
Revenue	$794,139	$533,148	+0.5%
Expenses	$838,780	$567,257	+0.5%
Net Income	$-44,641	$-34,109	+0.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Alicia Neu MD	President	5.00	Officer Director	$0	$0	$0
Bradley Warady MD	Vice President	5.00	Officer Director	$0	$0	$0
Stuart Goldstein MD	Secretary/Treasurer	5.00	Officer Director	$0	$0	$0
Jodi Smith	Board Member	5.00	Director	$0	$0	$0
Tom Blydt-Hansen MD	Board Member	5.00	Director	$0	$0	$0
Vikas Dharnidharka MD	Board Member	5.00	Director	$0	$0	$0
Michael Somers MD	Board Member	5.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$794,139	$838,780	$222,211	$-44,641
2023	$533,148	$567,257	$270,295	$-34,109
2022	$357,447	$445,798	$304,814	$-88,351
2021	$324,252	$553,946	$396,735	$-229,694
2020	$359,740	$670,691	$641,700	$-310,951
2019	$367,277	$745,693	$917,379	$-378,416
2018	$528,348	$779,139	$1,428,675	$-250,791

North American Pediatric Renal Transplant Case Study Inc